ATE483158T1 - Clostridientoxinaktivitätstests - Google Patents

Clostridientoxinaktivitätstests

Info

Publication number
ATE483158T1
ATE483158T1 AT06851224T AT06851224T ATE483158T1 AT E483158 T1 ATE483158 T1 AT E483158T1 AT 06851224 T AT06851224 T AT 06851224T AT 06851224 T AT06851224 T AT 06851224T AT E483158 T1 ATE483158 T1 AT E483158T1
Authority
AT
Austria
Prior art keywords
clostridial toxin
toxin activity
activity tests
cleavage site
fluorescent member
Prior art date
Application number
AT06851224T
Other languages
English (en)
Inventor
Ester Fernandez-Salas
Lanoe Steward
Kei Aoki
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38829390&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE483158(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE483158T1 publication Critical patent/ATE483158T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/33—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Clostridium (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Optical Filters (AREA)
  • Led Devices (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT06851224T 2005-04-05 2006-04-04 Clostridientoxinaktivitätstests ATE483158T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66890905P 2005-04-05 2005-04-05
PCT/US2006/012825 WO2008036060A2 (en) 2005-04-05 2006-04-04 Clostridial toxin activity assays

Publications (1)

Publication Number Publication Date
ATE483158T1 true ATE483158T1 (de) 2010-10-15

Family

ID=38829390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06851224T ATE483158T1 (de) 2005-04-05 2006-04-04 Clostridientoxinaktivitätstests

Country Status (9)

Country Link
US (1) US8067231B2 (de)
EP (2) EP1920248B1 (de)
AT (1) ATE483158T1 (de)
AU (1) AU2006340711C1 (de)
CA (1) CA2605160A1 (de)
DE (1) DE602006017237D1 (de)
DK (1) DK1920248T3 (de)
ES (1) ES2351942T3 (de)
WO (1) WO2008036060A2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
ATE442161T1 (de) * 2002-10-31 2009-09-15 Wisconsin Alumni Res Found Botulinumneurotoxin-b-rezeptoren und ihreverwendung
LT3031825T (lt) * 2008-03-14 2020-02-10 Allergan, Inc. Botulino toksino serotipo a aktyvumo imuninio tyrimo būdai
KR101604515B1 (ko) * 2008-03-14 2016-03-17 알러간, 인코포레이티드 면역-기반 보툴리눔 독소 세로타입 ａ 활성 검정
WO2010014608A1 (en) * 2008-07-28 2010-02-04 University Of Louisville Research Foundation, Inc. Methods and compositions for inhibition of neutrophil exocytosis
WO2010105234A1 (en) * 2009-03-13 2010-09-16 Allergan, Inc. Cells useful for immuno-based botulinum toxin serotype a activity assays
US11325954B2 (en) 2011-06-01 2022-05-10 Biomadison, Inc. Compositions and methods for stability testing of botulinum toxin
US9303285B2 (en) 2012-01-04 2016-04-05 Biomadison, Inc. Methods and compounds for increasing sensitivity of botulinum assays
LT2715355T (lt) 2011-06-01 2017-06-12 Biomadison, Inc. Ne fret (fluorescencijos rezonansinės energijos perdavimas) būdu atliekamas botulino tyrimas
US12422428B2 (en) 2011-06-01 2025-09-23 Biomadison, Inc. Compositions and methods for cell-based assays
US10908146B2 (en) 2011-06-01 2021-02-02 Biomadison, Inc. Compositions and methods for improving sensitivity in cell based assays
EP2788478B1 (de) * 2011-12-09 2017-08-23 Institut Pasteur Multiplex-immunoscreening-test
US10451621B2 (en) 2011-12-31 2019-10-22 Allergan, Inc. Highly sensitive cell-based assay to detect the presence of active botulinum neurotoxin serotype-A
EP2800973B1 (de) 2012-01-04 2018-05-16 Biomadison, Inc. Verfahren und verbindungen zur erhöhung der empfindlichkeit von botulinum-assays
CA2903809A1 (en) 2013-03-13 2014-10-02 Tahoe Institute for Rural Health Research, LLC Portable blood count monitor
EP3060677B1 (de) 2013-10-25 2018-07-04 Biomadison, Inc. Enzymassay mit doppelten fluorophoren
WO2015088477A1 (en) * 2013-12-09 2015-06-18 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Peptide substrates recognizable by type e botulinum neurotoxin
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
CN105535975B (zh) * 2015-12-21 2018-05-18 中国人民解放军第二军医大学 囊泡相关膜蛋白1在防治肠道病毒71型感染中的应用
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
RU2020123346A (ru) 2017-12-20 2022-01-20 Аллерган, Инк. Полипептиды клеточносвязывающего домена ботулинического токсина и способы применения для лечения расстройств, связанных с фиброзом
CN116693638B (zh) * 2023-05-15 2024-03-08 西北农林科技大学 Pg1-lc蛋白作为snap-25的水解酶的应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5747641A (en) 1989-12-21 1998-05-05 Biogen Inc Tat-derived transport polypeptide conjugates
US5804604A (en) 1989-12-21 1998-09-08 Biogen, Inc. Tat-derived transport polypeptides and fusion proteins
AU7492291A (en) 1990-02-26 1991-09-18 Board Of Trustees Of The Leland Stanford Junior University Identification and expression of insect steroid receptor dna sequences
US5364791A (en) 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
DE69334150T2 (de) 1992-05-14 2008-03-13 Baylor College Of Medicine, Houston Mutierte steroidhormonrezeptoren, methoden für ihre benutzung und molekularer schalter für gentherapie
ES2341140T3 (es) 1993-06-10 2010-06-15 Allergan, Inc. Tratamiento de trastornos y afecciones neuromusculares con un seropositivo botulinico diferente.
CA2164626C (en) 1993-06-10 2004-11-23 K. Roger Aoki Multiple botulinum toxins for treating neuromuscular disorders and conditions
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
US5814618A (en) 1993-06-14 1998-09-29 Basf Aktiengesellschaft Methods for regulating gene expression
US6974578B1 (en) 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5962637A (en) 1994-06-03 1999-10-05 Microbiological Research Authority Toxin assay
US6495518B1 (en) 1994-06-13 2002-12-17 Vanderbilt University Method for importing biologically active molecules into cells
US5807746A (en) 1994-06-13 1998-09-15 Vanderbilt University Method for importing biologically active molecules into cells
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US5625048A (en) 1994-11-10 1997-04-29 The Regents Of The University Of California Modified green fluorescent proteins
EP0845043B1 (de) 1995-07-28 2007-06-27 Marie Curie Cancer Care Transportproteine und deren verwendungen
FR2739621B1 (fr) 1995-10-05 1997-12-05 Centre Nat Rech Scient Peptides utilisables comme vecteurs pour l'adressage intracellulaire de molecules actives
US5804387A (en) 1996-02-01 1998-09-08 The Board Of Trustees Of The Leland Stanford Junior University FACS-optimized mutants of the green fluorescent protein (GFP)
US6072041A (en) 1996-06-03 2000-06-06 Case Western Reserve University Fusion proteins for protein delivery
US6124128A (en) 1996-08-16 2000-09-26 The Regents Of The University Of California Long wavelength engineered fluorescent proteins
US5965699A (en) * 1996-11-06 1999-10-12 The United States Of America As Represented By The Secretary Of The Army Assay for the proteolytic activity of serotype a from clostridium botulinum
US6017735A (en) 1997-01-23 2000-01-25 Marie Curie Cancer Care Materials and methods for intracellular transport and their uses
DE69818987T2 (de) 1997-05-21 2004-07-29 The Board Of Trustees Of The Leland Stanford Junior University, Stanford Zusammensetzung und verfahren zur verzögerung des transports durch biologische membranen
US6248558B1 (en) 1998-03-31 2001-06-19 Vanderbilt University Sequence and method for genetic engineering of proteins with cell membrane translocating activity
CA2330560A1 (en) 1998-04-28 1999-11-04 Washington University Methods for transducing fusion molecules
US7090976B2 (en) * 1999-11-10 2006-08-15 Rigel Pharmaceuticals, Inc. Methods and compositions comprising Renilla GFP
US6140132A (en) 1998-06-09 2000-10-31 The Regents Of The University Of California Fluorescent protein sensors for measuring the pH of a biological sample
EP1137664A2 (de) 1998-12-10 2001-10-04 Washington University Protein-transduktionssystem und methoden seiner verwendung
JP2003514765A (ja) 1999-02-28 2003-04-22 ワシントン ユニバーシティー 新規形質導入分子およびその使用方法
US6767544B2 (en) 2002-04-01 2004-07-27 Allergan, Inc. Methods for treating cardiovascular diseases with botulinum toxin
GB9930519D0 (en) 1999-12-24 2000-02-16 Phogen Limited Uses of transport proteins
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
FR2809733B1 (fr) 2000-06-02 2004-04-30 Inst Nat Sante Rech Med Substrat peptidique reconnu par la toxine botulique de type bont/b et son utilisation pour doser et/ou detecter ladite toxine ou des inhibiteurs correspondants
US20040219619A1 (en) * 2000-07-21 2004-11-04 Ester Fernandez-Salas Methods of identifying compounds that alter toxin persistence and/or protease activity
CA2417454A1 (en) 2000-07-31 2002-02-07 Active Motif Peptide-mediated delivery of molecules into cells
EP1419390B1 (de) 2000-09-25 2007-11-14 U.S. Medical Research Institute of Infectious Diseases Hoch-durchsatz assays für proteolytische aktivitäten von clostridium neurotoxinen
US6423319B1 (en) 2000-10-04 2002-07-23 Allergan Sales, Inc. Methods for treating muscle injuries
US7349691B2 (en) 2001-07-03 2008-03-25 Microsoft Corporation System and apparatus for performing broadcast and localcast communications
US7332567B2 (en) 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
US20060063221A1 (en) * 2004-09-21 2006-03-23 Williams Dudley J Lanthanide-based substrates and methods for determining clostridial toxin activity
US7208285B2 (en) 2001-08-28 2007-04-24 Allergan, Inc. Fret protease assays for botulinum serotype A/E toxins
US7374896B2 (en) * 2001-08-28 2008-05-20 Allergan, Inc. GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
JP4423851B2 (ja) 2002-02-28 2010-03-03 日本精工株式会社 直動案内装置の製造方法
US6921538B2 (en) 2002-05-10 2005-07-26 Allergan, Inc. Therapeutic treatments for neuropsychiatric disorders
JP4067525B2 (ja) * 2002-09-13 2008-03-26 オーチス エレベータ カンパニー 人間輸送手段用の安全監視
US7183066B2 (en) * 2002-09-27 2007-02-27 Allergan, Inc. Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
WO2004031355A2 (en) 2002-10-01 2004-04-15 University Of Maryland Methods for identifying inhibitors of botulinum neurotoxins
US7166692B2 (en) 2003-03-04 2007-01-23 Canbrex Bio Science Walkersville, Inc. Intracellular delivery of small molecules, proteins, and nucleic acids
EP2502930B1 (de) * 2003-12-19 2016-06-29 Wisconsin Alumni Research Foundation Verfahren und zusammensetzungen zum nachweis von botulinum-neurotoxin
ATE380880T1 (de) 2004-05-05 2007-12-15 Pharmaleads Mittels botulinumtoxin a (bont/a) erkennbare peptidsubstrate und verwendung
US7399607B2 (en) 2004-09-22 2008-07-15 Allergan, Inc. Fluorescence polarization assays for determining clostridial toxin activity

Also Published As

Publication number Publication date
US8067231B2 (en) 2011-11-29
AU2006340711C1 (en) 2013-02-07
EP1920248A2 (de) 2008-05-14
EP2264458A1 (de) 2010-12-22
EP1920248B1 (de) 2010-09-29
AU2006340711B2 (en) 2012-02-23
DE602006017237D1 (en) 2010-11-11
DK1920248T3 (da) 2010-12-13
WO2008036060A3 (en) 2008-09-12
ES2351942T3 (es) 2011-02-14
CA2605160A1 (en) 2006-10-05
AU2006340711A1 (en) 2007-11-15
WO2008036060A2 (en) 2008-03-27
AU2006340711A8 (en) 2008-08-07
US20090191583A1 (en) 2009-07-30

Similar Documents

Publication Publication Date Title
ATE483158T1 (de) Clostridientoxinaktivitätstests
DE602006014812D1 (de) Lostridientoxinaktivität
CY1114839T1 (el) Πρωτεϊνες συγχωνευσεως περιλαμβανουσες μια μη κυτταροτοξικη πρωτεαση, μια ομαδα στοχευσεως, μια θεση αποκοπης πρωτεασης και εναν τομεα μετατοπισεως
NO20075471L (no) Betjening av en eller flere drivstoffautomater
BRPI0510674A (pt) variantes fc otimizadas
DK2018441T3 (da) Mærkede mikroorganismer og fremgangsmåde til mærkning
EP1898483A4 (de) Brennstoffzellsystem
WO2008039769A3 (en) Methods and devices for analyzing small rna molecules
TW200614966A (en) Analyte monitoring system with wireless alram
ITRM20040447A1 (it) Sistema di fornitura di seminari interattivi, e relativo metodo.
MX2010001657A (es) Reguladores de mmp-9 y usos de los mismos.
NO20044051L (no) Analyse for ACTRIIB-kinase aktivitet
CY1113816T1 (el) Μορια ταυτοποιησης τα οποια ρυθμιζουν τις αλληλεπιδρασεις πρωτεϊνης-πρωτεϊνης με τη χρηση ανταποκριτων που ενεργοποιουνται με μια πρωτεαση
DK1454992T3 (da) Anaplastisk lymfomakinaseassay, reagenser og sammensætninger deraf
MX2010010309A (es) Ceculas hospederas y metodos para producir proteinas que contienen enlace de disulfuro.
DE602005016800D1 (de) Hif-prolylhydroxylase-aktivitätstest
EA200702193A1 (ru) Гликозилирование белков
WO2005089505A3 (en) Detection, isolation and uses of renalase (monoamine oxidase c)
TR200400184T2 (tr) Herbisidal bileşiklere tolerans veren DNA molekülleri
WO2006107611A3 (en) Detection of an immune response to gdf-8 modulating agents
ATE460487T1 (de) Screening-test für ribosomale antibiotika
ATE550077T1 (de) Armaturendruckplattenset sowie armaturendruckplatte
WO2008143702A3 (en) Anti-mrp3 antibodies and methods of use
DK1660886T3 (da) Indretning til detektion af biokemisk aktivitetet indeholdende gap junctions
SE0400475D0 (sv) Collecton of a specimen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties